These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36082151)

  • 1. MRI Extraprostatic Extension Grade: Accuracy and Clinical Incremental Value in the Assessment of Extraprostatic Cancer.
    Xiang JY; Huang XS; Xu JX; Huang RH; Zheng XZ; Xue LM; Liu YL
    Biomed Res Int; 2022; 2022():3203965. PubMed ID: 36082151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External Validation of the Extraprostatic Extension Grade on MRI and Its Incremental Value to Clinical Models for Assessing Extraprostatic Cancer.
    Xu L; Zhang G; Zhang X; Bai X; Yan W; Xiao Y; Sun H; Jin Z
    Front Oncol; 2021; 11():655093. PubMed ID: 33869062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Head-to-head comparison between multiparametric MRI, the partin tables, memorial sloan kettering cancer center nomogram, and CAPRA score in predicting extraprostatic cancer in patients undergoing radical prostatectomy.
    Zanelli E; Giannarini G; Cereser L; Zuiani C; Como G; Pizzolitto S; Crestani A; Valotto C; Ficarra V; Girometti R
    J Magn Reson Imaging; 2019 Nov; 50(5):1604-1613. PubMed ID: 30957321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for the Prediction of Extraprostatic Disease-A Risk Model for Patient-tailored Risk Stratification When Planning Radical Prostatectomy.
    Nyarangi-Dix J; Wiesenfarth M; Bonekamp D; Hitthaler B; Schütz V; Dieffenbacher S; Mueller-Wolf M; Roth W; Stenzinger A; Duensing S; Roethke M; Teber D; Schlemmer HP; Hohenfellner M; Radtke JP
    Eur Urol Focus; 2020 Nov; 6(6):1205-1212. PubMed ID: 30477971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adding multiparametric MRI to the MSKCC and Partin nomograms for primary prostate cancer: Improving local tumor staging?
    Jansen BHE; Nieuwenhuijzen JA; Oprea-Lager DE; Yska MJ; Lont AP; van Moorselaar RJA; Vis AN
    Urol Oncol; 2019 Mar; 37(3):181.e1-181.e6. PubMed ID: 30558983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of pathological stage based on clinical stage, serum prostate-specific antigen, and biopsy Gleason score: Partin Tables in the contemporary era.
    Tosoian JJ; Chappidi M; Feng Z; Humphreys EB; Han M; Pavlovich CP; Epstein JI; Partin AW; Trock BJ
    BJU Int; 2017 May; 119(5):676-683. PubMed ID: 27367645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability of the different versions of Partin tables in predicting extraprostatic extension of prostate cancer: a systematic review and meta-analysis.
    Eissa A; Elsherbiny A; Zoeir A; Sandri M; Pirola G; Puliatti S; Del Prete C; Sighinolfi MC; Micali S; Rocco B; Bianchi G
    Minerva Urol Nefrol; 2019 Oct; 71(5):457-478. PubMed ID: 30957478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate MRI added to CAPRA, MSKCC and Partin cancer nomograms significantly enhances the prediction of adverse findings and biochemical recurrence after radical prostatectomy.
    Sandeman K; Eineluoto JT; Pohjonen J; Erickson A; Kilpeläinen TP; Järvinen P; Santti H; Petas A; Matikainen M; Marjasuo S; Kenttämies A; Mirtti T; Rannikko A
    PLoS One; 2020; 15(7):e0235779. PubMed ID: 32645056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic performance of prediction models for extraprostatic extension in prostate cancer: a systematic review and meta-analysis.
    Zhu M; Gao J; Han F; Yin L; Zhang L; Yang Y; Zhang J
    Insights Imaging; 2023 Aug; 14(1):140. PubMed ID: 37606802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of Partin tables and development of a preoperative nomogram for Japanese patients with clinically localized prostate cancer using 2005 International Society of Urological Pathology consensus on Gleason grading: data from the Clinicopathological Research Group for Localized Prostate Cancer.
    Naito S; Kuroiwa K; Kinukawa N; Goto K; Koga H; Ogawa O; Murai M; Shiraishi T;
    J Urol; 2008 Sep; 180(3):904-9; discussion 909-10. PubMed ID: 18635221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR image quality in local staging of prostate cancer: Role of PI-QUAL in the detection of extraprostatic extension.
    Ponsiglione A; Stanzione A; Califano G; De Giorgi M; Collà Ruvolo C; D'Iglio I; Morra S; Longo N; Imbriaco M; Cuocolo R
    Eur J Radiol; 2023 Sep; 166():110973. PubMed ID: 37453275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing 3-T multiparametric MRI and the Partin tables to predict organ-confined prostate cancer after radical prostatectomy.
    Gupta RT; Faridi KF; Singh AA; Passoni NM; Garcia-Reyes K; Madden JF; Polascik TJ
    Urol Oncol; 2014 Nov; 32(8):1292-9. PubMed ID: 24863013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An updated model for predicting side-specific extraprostatic extension in the era of MRI-targeted biopsy.
    Martini A; Wever L; Soeterik TFW; Rakauskas A; Fankhauser CD; Grogg JB; Checcucci E; Amparore D; Haiquel L; Rodriguez-Sanchez L; Ploussard G; Qiang P; Affentranger A; Marquis A; Marra G; Ettala O; Zattoni F; Falagario UG; De Angelis M; Kesch C; Apfelbeck M; Al-Hammouri T; Kretschmer A; Kasivisvanathan V; Preisser F; Lefebvre E; Olivier J; Radtke JP; Carrieri G; Moro FD; Boström P; Jambor I; Gontero P; Chiu PK; John H; Macek P; Porpiglia F; Hermanns T; van den Bergh RCN; van Basten JA; Gandaglia G; Valerio M;
    Prostate Cancer Prostatic Dis; 2024 Sep; 27(3):520-524. PubMed ID: 38182804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-Stop-Shop Whole-Body
    Thalgott M; Düwel C; Rauscher I; Heck MM; Haller B; Gafita A; Gschwend JE; Schwaiger M; Maurer T; Eiber M
    J Nucl Med; 2018 Dec; 59(12):1850-1856. PubMed ID: 29794224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can Radiologic Staging With Multiparametric MRI Enhance the Accuracy of the Partin Tables in Predicting Organ-Confined Prostate Cancer?
    Gupta RT; Brown AF; Silverman RK; Tay KJ; Madden JF; George DJ; Polascik TJ
    AJR Am J Roentgenol; 2016 Jul; 207(1):87-95. PubMed ID: 27064383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Validation of Models to Predict Pathological Outcomes of Radical Prostatectomy in Regional and National Cohorts.
    Ötleş E; Denton BT; Qu B; Murali A; Merdan S; Auffenberg GB; Hiller SC; Lane BR; George AK; Singh K
    J Urol; 2022 Feb; 207(2):358-366. PubMed ID: 34551595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decision curve analysis to compare 3 versions of Partin Tables to predict final pathologic stage.
    Augustin H; Sun M; Isbarn H; Pummer K; Karakiewicz P
    Urol Oncol; 2012; 30(4):396-401. PubMed ID: 20884254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extraprostatic Tumor Extension: Comparison of Preoperative Multiparametric MRI Criteria and Histopathologic Correlation after Radical Prostatectomy.
    Park KJ; Kim MH; Kim JK
    Radiology; 2020 Jul; 296(1):87-95. PubMed ID: 32368959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate Magnetic Resonance Imaging Analyses, Clinical Parameters, and Preoperative Nomograms in the Prediction of Extraprostatic Extension.
    Majchrzak N; Cieśliński P; Głyda M; Karmelita-Katulska K
    Clin Pract; 2021 Oct; 11(4):763-774. PubMed ID: 34698089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Grading System for the Assessment of Risk of Extraprostatic Extension of Prostate Cancer at Multiparametric MRI.
    Mehralivand S; Shih JH; Harmon S; Smith C; Bloom J; Czarniecki M; Gold S; Hale G; Rayn K; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Turkbey B
    Radiology; 2019 Mar; 290(3):709-719. PubMed ID: 30667329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.